Jan 27 2010
Sunridge International's, (OTC Bulletin Board: SNDZ) patented "PNT" procedure was the topic of discussion in one of Health News Digest's recent articles published on January 24, 2010.
HealthNewsDigest.com network publishes 24/7, covering breaking news, articles, stories, and features on health, science and the environment. HND's content currently appears in 164 countries, being distributed through their website as well as Google Worldwide, Topix World News, Congoo World News, and an over 4,000 additional websites.
G. Richard Smith, CEO of Sunridge International, stated, "Articles like this go a long way to help inform the public of how severe glaucoma is and what preventative actions should be taken. As mentioned in the article, 'PNT can also be used for newly diagnosed patients who have yet to undergo pharmaceutical approaches,' and it is our goal at Sunridge International to expand our marketing efforts so that one day the newly diagnosed population, along with the current glaucoma sufferers from around the globe can receive the 'PNT' procedure to help stop the progression of this disease."
Glaucoma is the second leading cause of blindness, effecting over 70 million people worldwide. PNT has been proven (through studies completed over the last 10 yrs) to be a safe and effective treatment with no adverse side effects associated with it, unlike typical forms of glaucoma treatment.
SOURCE Sunridge International
Targeted ocular spectroscopy shines new light on retinal health